Literature DB >> 11459389

Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach.

S Kéri1, O Kelemen, G Benedek, Z Janka.   

Abstract

BACKGROUND: The aim of this study was to assess visual information processing and cognitive functions in unaffected siblings of patients with schizophrenia, bipolar disorder and control subjects with a negative family history.
METHODS: The siblings of patients with schizophrenia (N = 25), bipolar disorder (N = 20) and the controls subjects (N = 20) were matched for age, education, IQ, and psychosocial functioning, as indexed by the Global Assessment of Functioning scale. Visual information processing was measured using two visual backward masking (VBM) tests (target location and target identification). The evaluation of higher cognitive functions included spatial and verbal working memory, Wisconsin Card Sorting Test, letter fluency, short/long delay verbal recall and recognition.
RESULTS: The relatives of schizophrenia patients were impaired in the VBM procedure, more pronouncedly at short interstimulus intervals (14, 28, 42 ms) and in the target location task. Marked dysfunctions were also found in the spatial working memory task and in the long delay verbal recall test. In contrast, the siblings of patients with bipolar disorder exhibited spared performances with the exception of a deficit in the long delay recall task.
CONCLUSIONS: Dysfunctions of sensory-perceptual analysis (VBM) and working memory for spatial information distinguished the siblings of schizophrenia patients from the siblings of individuals with bipolar disorder. Verbal recall deficit was present in both groups, suggesting a common impairment of the fronto-hippocampal system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459389     DOI: 10.1017/s0033291701004068

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  51 in total

1.  Visual masking by object substitution in schizophrenia.

Authors:  M F Green; J K Wynn; B Breitmeyer; K I Mathis; K H Nuechterlein
Journal:  Psychol Med       Date:  2010-11-16       Impact factor: 7.723

2.  Reduced contextual effects on visual contrast perception in schizophrenia and bipolar affective disorder.

Authors:  M-P Schallmo; S R Sponheim; C A Olman
Journal:  Psychol Med       Date:  2015-08-28       Impact factor: 7.723

Review 3.  Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder.

Authors:  Jonathan B Savitz; Mark Solms; Rajkumar S Ramesar
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

5.  Cognitive deficits in first-degree relatives of bipolar patients: the use of homogeneous subgroups in the search of cognitive endophenotypes.

Authors:  Julia Volkert; J Haubner; J Kazmaier; F Glaser; J Kopf; S Kittel-Schneider; A Reif
Journal:  J Neural Transm (Vienna)       Date:  2016-06-08       Impact factor: 3.575

6.  Neurocognitive impairment in unaffected siblings of youth with bipolar disorder.

Authors:  A E Doyle; J Wozniak; T E Wilens; A Henin; L J Seidman; C Petty; R Fried; L M Gross; S V Faraone; J Biederman
Journal:  Psychol Med       Date:  2008-12-11       Impact factor: 7.723

7.  Stability of visual masking performance in recent-onset schizophrenia: an 18-month longitudinal study.

Authors:  Junghee Lee; Keith H Nuechterlein; Kenneth L Subotnik; Catherine A Sugar; Joseph Ventura; Denise Gretchen-Doorly; Kimberly Kelly; Michael F Green
Journal:  Schizophr Res       Date:  2008-05-01       Impact factor: 4.939

Review 8.  Pediatric bipolar disorder: evidence for prodromal states and early markers.

Authors:  Joan L Luby; Neha Navsaria
Journal:  J Child Psychol Psychiatry       Date:  2010-01-18       Impact factor: 8.982

9.  Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Authors:  D M Cannon; J K Klaver; S K Gandhi; G Solorio; S A Peck; K Erickson; N Akula; J Savitz; W C Eckelman; M L Furey; B J Sahakian; F J McMahon; W C Drevets
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

10.  Cognitive deficits in psychiatric disorders: Current status.

Authors:  J K Trivedi
Journal:  Indian J Psychiatry       Date:  2006-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.